316 related articles for article (PubMed ID: 31841375)
1. Targeting Cell Metabolism as Cancer Therapy.
Ngoi NYL; Eu JQ; Hirpara J; Wang L; Lim JSJ; Lee SC; Lim YC; Pervaiz S; Goh BC; Wong ALA
Antioxid Redox Signal; 2020 Feb; 32(5):285-308. PubMed ID: 31841375
[No Abstract] [Full Text] [Related]
2. Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy.
Li J; Eu JQ; Kong LR; Wang L; Lim YC; Goh BC; Wong ALA
Molecules; 2020 Oct; 25(20):. PubMed ID: 33092283
[TBL] [Abstract][Full Text] [Related]
3. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
4. Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions.
Vernieri C; Casola S; Foiani M; Pietrantonio F; de Braud F; Longo V
Cancer Discov; 2016 Dec; 6(12):1315-1333. PubMed ID: 27872127
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer.
Avolio R; Matassa DS; Criscuolo D; Landriscina M; Esposito F
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947673
[TBL] [Abstract][Full Text] [Related]
6. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
7. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy.
Li X; Wenes M; Romero P; Huang SC; Fendt SM; Ho PC
Nat Rev Clin Oncol; 2019 Jul; 16(7):425-441. PubMed ID: 30914826
[TBL] [Abstract][Full Text] [Related]
8. Iron as a Central Player and Promising Target in Cancer Progression.
Jung M; Mertens C; Tomat E; Brüne B
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641920
[TBL] [Abstract][Full Text] [Related]
9. Targeting metabolic dependencies in pediatric cancer.
Issaq SH; Heske CM
Curr Opin Pediatr; 2020 Feb; 32(1):26-34. PubMed ID: 31789976
[TBL] [Abstract][Full Text] [Related]
10. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol metabolism: New functions and therapeutic approaches in cancer.
Xu H; Zhou S; Tang Q; Xia H; Bi F
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188394. PubMed ID: 32698040
[TBL] [Abstract][Full Text] [Related]
12. ROS homeostasis and metabolism: a critical liaison for cancer therapy.
Kim J; Kim J; Bae JS
Exp Mol Med; 2016 Nov; 48(11):e269. PubMed ID: 27811934
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the role of AMP-activated protein kinase in metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic pathways for anti-tumor treatment.
Tyszka-Czochara M; Konieczny P; Majka M
J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279304
[TBL] [Abstract][Full Text] [Related]
14. Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.
Yin Z; Bai L; Li W; Zeng T; Tian H; Cui J
J Exp Clin Cancer Res; 2019 Sep; 38(1):403. PubMed ID: 31519198
[TBL] [Abstract][Full Text] [Related]
15. Potential Mechanisms Connecting Purine Metabolism and Cancer Therapy.
Yin J; Ren W; Huang X; Deng J; Li T; Yin Y
Front Immunol; 2018; 9():1697. PubMed ID: 30105018
[TBL] [Abstract][Full Text] [Related]
16. Moonlighting Metabolic Enzymes in Cancer: New Perspectives on the Redox Code.
Jiang J; Peng L; Wang K; Huang C
Antioxid Redox Signal; 2021 May; 34(13):979-1003. PubMed ID: 32631077
[No Abstract] [Full Text] [Related]
17. Metabolic targeting of malignant tumors: small-molecule inhibitors of bioenergetic flux.
Mathupala SP
Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):6-14. PubMed ID: 21110820
[TBL] [Abstract][Full Text] [Related]
18. One-carbon metabolism for cancer diagnostic and therapeutic approaches.
Asai A; Konno M; Koseki J; Taniguchi M; Vecchione A; Ishii H
Cancer Lett; 2020 Feb; 470():141-148. PubMed ID: 31759958
[TBL] [Abstract][Full Text] [Related]
19. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.
Magaway C; Kim E; Jacinto E
Cells; 2019 Dec; 8(12):. PubMed ID: 31817676
[TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
Yoshida GJ
J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
